Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572260 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study of Daptomycin for Antimicrobial Prophylaxis
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT00572260 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 11 participants.
The verdict
NCT00572260, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of surgical site infection, and to evaluate the occurrence of adverse events.
Interventions
- DRUG daptomycin 6 mg/kg IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00572260
The ClinicalTrials.gov registry entry for NCT00572260 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which daptomycin 6 mg/kg IV is the first listed.
NCT00572260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00572260 about?
NCT00572260 is a clinical study titled "A Pilot Study of Daptomycin for Antimicrobial Prophylaxis". The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of surgical site infection, and to evaluate the occurrence of adverse events.
What is the current status of trial NCT00572260?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-01. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00572260?
The interventions under investigation include: daptomycin 6 mg/kg IV (DRUG).
Who is sponsoring clinical trial NCT00572260?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.